Monoamine Oxidase Inhibitors
- Name
- Monoamine Oxidase Inhibitors
- Accession Number
- DBCAT001004 (DBCAT002868)
- Description
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
- ATC Classification
- Drugs
Drug Drug Description 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline Potent reversible inhibitor of phenylethanolamine N-methyltransferase. Amiflamine Amiflamine is a small molecule drug. Amiflamine has a monoisotopic molecular weight of 192.16 Da. Benmoxin For the treatment of depression. Brofaromine Not Annotated Caroxazone For the treatment of depression. Clorgiline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Furazolidone A drug for the treatment of infectious diarrhea. Harmaline Not Annotated Harmine Not Available Hydracarbazine Was used for the treatment of hypertension . Iproniazid For the treatment of depression (originally intended to treat tuberculosis). Isocarboxazid A monoamine oxidase inhibitor used to treat enduring and debilitating symptoms of depression following inadequate clinical response to other antidepressant drugs. Lazabemide Lazabemide is a small molecule drug. Lazabemide has a monoisotopic molecular weight of 199.05 Da. Linezolid An oxazolidinone antibiotic used to treat infections by susceptible strains of aerobic Gram-positive bacteria. Mebanazine For the treatment of depression. Methylene blue An oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia. Milacemide Milacemide is a small molecule drug. Milacemide has a monoisotopic molecular weight of 144.13 Da. Minaprine For the treatment of depression Moclobemide A monoamine oxidase inhibitor used in the treatment of major depressive disorder and bipolar disorder. Mofegiline Mofegiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Mofegiline is a monoamine oxydase (MAO)-inhibitor type B. Mofegiline has a monoisotopic... Nialamide Withdrawn from the Canadian, US, and UK markets in 1963 due to interactions with food products containing tyrosine. Octamoxin For the treatment of depression. Pargyline For the treatment of moderate to severe hypertension. Phenelzine A monoamine oxidase inhibitor used to treat atypical, nonendogenous, or neurotic depression. Pheniprazine For the treatment of depression, schizophrenia, and angina pectoris. Phenoxypropazine For the treatment of depression. Pirlindole For the treatment of major depression. It is being studied in the treatment of fibromyalgia pain syndrome. One study determined that the effect of pirlindole on sensorimotor performance while driving... Pivhydrazine For the treatment of depression. Procaine A local anesthetic used for anesthesia, peripheral nerve block, and spinal nerve block. Procarbazine An antineoplastic agent indicated for the treatment of stage III and stage IV Hodgkin's disease in combination with other chemotherapeutic agents. Rasagiline An irreversible inhibitor of monoamine oxidase used for the symptomatic management of idiopathic Parkinson's disease as initial monotherapy and as adjunct therapy to levodopa. Safinamide A MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson's disease during "off" episodes. Safrazine For the treatment of depression. Selegiline A monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson's. Toloxatone For the treatment of major depressive disorder. Tranylcypromine A monoamine oxidase inhibitor used to treat major depressive disorder. Viloxazine A selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children.